NRX Pharmaceuticals, Inc. Common Stock (NRXP) Stock Price

NRXPStock
$3.67+30.68%52W
Market Cap$158.90M
P/E
PEG Ratio
Div yield
Beta2.04

NRXP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)83.12%
Price vs S&P 500 (4W)-5.59%
VGM Score67.42

NRXP Earnings Surprise History

Q2 25-0.98est. -0.23
Q3 25-0.51est. -0.02
Q4 250.18est. -0.08
Q1 26-0.04est. -0.11
Q2 26-0.24est. -0.13

NRXP Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.20
4.18
4.18
4.18

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
NRXPNRX Pharmaceuticals, Inc. Common Stock
B$3.67
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About NRX Pharmaceuticals, Inc. Common Stock

NRX Pharmaceuticals is a clinical-stage pharmaceutical company developing small-molecule therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The company has commercialized ZYESAMI (Aviptadil) for COVID-related respiratory failure and is advancing NRX-100/101, a sequential treatment regimen for bipolar depression in patients with acute suicidal ideation. Its pipeline targets unmet needs in critical care and psychiatry.